Last updated: September 29, 2025
Introduction
Patent WO2006128255, assigned to generics and research entities, pertains to a novel pharmaceutical compound or formulation involving a specific drug candidate. Under the auspices of the World Intellectual Property Organization (WIPO), this application exemplifies contemporary strategies in drug patenting, encompassing claims that span chemical compositions, methods of use, and manufacturing processes. Analyzing this patent's scope and the broader landscape provides crucial insights into its potential enforceability, competitive positioning, and technological significance.
Scope of Patent WO2006128255
Patent Classification and Focus
WO2006128255 primarily falls under the International Patent Classification (IPC) codes associated with pharmaceutical compositions and active compounds. While the precise IPC code necessitates reviewing the published document, patents of this type typically align with classes such as A61K (prepared medicaments) and C07D (heterocyclic compounds), indicating a focus on a specific chemical entity with therapeutic applications.
Its scope likely encompasses:
- Chemical Compound or Derivative: The core inventive aspect involves a specific chemical entity, which can be a novel molecule, a derivative, or a salt form demonstrating improved pharmacological profiles.
- Method of Synthesis/Preparation: The patent may disclose a synthetic route, emphasizing novel methodologies to produce the compound efficiently.
- Therapeutic Use: It potentially claims therapeutic methods, such as indications for certain diseases or conditions, based on the pharmacodynamic properties of the compound.
- Formulations: The patent could cover specific formulations—e.g., controlled-release forms—that enhance bioavailability or patient compliance.
- Combination Therapies: The scope might extend to using the compound synergistically with other agents, broadening the patent's coverage.
Geographical Scope and Patent Family
The WO (Patent Cooperation Treaty) application provides a priority framework, permitting subsequent national or regional filings. It's essential to evaluate subsequent national phase entries—particularly filings in major markets (U.S., Europe, Japan, China)—to gauge the patent's territorial breadth.
The patent family associated with WO2006128255 might include:
- National equivalents that specify jurisdictional claims.
- Continuation or divisional applications focusing on specific aspects, such as formulations or methods.
Duration and Expiry
Given the filing date (around 2006), typical patent lifespan considerations apply—patents generally expire 20 years after the earliest priority date, usually around 2026–2028, depending on jurisdiction-specific adjustments and patent term extensions.
Claims Analysis
Patent claims define the scope of protection and are pivotal in assessing enforceability and competitive risk.
Types of Claims
- Compound Claims: These likely specify a chemical entity with defined structural features. For example, claims may detail a general formula encompassing a class of derivatives with specific substituents.
- Use Claims: Protective claims might specify methods of treating particular diseases—e.g., cancers, inflammatory disorders—using the compound.
- Process Claims: These detail unique synthetic routes, possibly providing a technical advantage or novelty.
- Formulation Claims: Claims that cover specific pharmaceutical compositions—such as tablets, capsules, or injectables—containing the compound.
Claim Elements and Novelty
Key elements include:
- Structural Specificity: The claims probably pin down a unique chemical scaffold not previously described in prior art.
- Unique Substituents or Modifications: Novelty can hinge on particular substituents that confer advantageous pharmacokinetics or pharmacodynamics.
- Therapeutic Applications: Claims referencing specific disease targets provide strategic leverage in patent enforcement and licensing.
Any overlap with known compounds or prior art in the chemical or therapeutic space could diminish the scope or room for challenge. For instance, if the compound is a derivative of an existing molecule, claims must distinguish it based on inventive modifications.
Claim Strategy and Patent Strength
- Broad, independent claims covering the chemical core with narrow dependent claims covering specific derivatives enhance enforceability.
- Use claims targeting methods of use to prevent off-label patent circumvention.
- The robustness depends on the novelty, inventive step, and clarity of the claimed features.
Patent Landscape and Competitive Environment
Prior Art and Overlapping Patents
A comprehensive landscape analysis involves:
- Chemical Space: Patents related to compounds with similar structures or pharmacological activities. For example, other patents on structurally related heterocycles or therapeutic classes can impact freedom-to-operate.
- Therapeutic Space: Overlapping patents in indications like oncology, neurology, or metabolic diseases can influence market entry strategies.
- Manufacturing and Formulation Patents: These may provide additional layers of protection or potential freedom-to-operate issues.
Literature and patent databases reveal several prior art references, possibly including:
- Earlier anti-inflammatory or anticancer compounds with related structures.
- Syntheses and derivatives claimed in patents from competitors like Roche, Novartis, or generic companies.
Patent Clusters and Related Innovation
The technological landscape appears to cluster around:
- Chemical Core Structures: Specifically modified heterocyclic scaffolds.
- Combination Regimens: Use of this compound in combination therapies.
- Delivery Technologies: Nanoformulations or controlled-release systems.
The patent family surrounding WO2006128255 serves as a strategic shield or an offensive tool depending on infringement risks and licensing potential.
Legal and Enforcement Considerations
Given the age of the patent application (filing date circa 2006), current enforceability may be limited by expiration unless extended via supplementary protections, such as patent term extensions or pediatric extensions, in specific jurisdictions.
Implications for Stakeholders
- Pharmaceutical Developers: Should scrutinize the patent claims to avoid infringement; likewise, evaluate opportunities for licensing.
- Generic Manufacturers: Need to assess whether the patent's claims are narrow or broad, and whether any invalidity challenges or design-arounds are feasible.
- Researchers: Can analyze the scope of the patent to identify unmet needs or potential innovation pathways.
Key Takeaways
- Scope of WO2006128255 likely encompasses a novel chemical compound with broad claims covering the molecule, its uses, and formulations; however, detailed claim language is crucial for precise assessment.**
- Claims emphasize structural novelty, therapeutic application, and synthesis, positioning the patent within the competitive landscape of targeted drug development.**
- The patent landscape is dense with overlapping patents, particularly in heterocyclic compounds and therapeutic indications, requiring careful freedom-to-operate analysis.
- Potential patent expiry around 2026–2028 could influence market strategies, although extensions may be applicable depending on jurisdiction.
- Proceedings should consider patent validity, potential for invalidation, and enforceability given prior art and overlapping patents.
FAQs
1. What is the core innovation in WO2006128255?
The core innovation likely involves a specific chemical compound or derivative with unique structural features, demonstrating desired pharmacological effects, thereby extending patent protection to novel molecules with therapeutic uses.
2. How does this patent impact generic drug manufacturers?
The patent's scope could restrict generic entry for a defined period unless challenged or circumvented through inventive strategies, especially if the claims are broad and enforceable.
3. Are the claims in WO2006128255 broad enough to cover multiple therapeutic applications?
Typically, pharmaceutical patents aim for broad chemical claims and narrow use-specific claims. The scope's breadth depends on the claim language, which should specify particular indications or target populations.
4. Has the patent landscape around this compound been extensively litigated or challenged?
Given the age and typical lifecycle, there may have been patent challenges or licensing negotiations; checking legal databases would provide confirmation.
5. What strategic considerations should companies assess regarding this patent?
Stakeholders should analyze claim strength, territorial coverage, potential for invalidity, and options for licensing, licensing-in, or designing around the patent.
References
[1] WIPO Patent Publication WO2006128255 — Title and Abstract (specific document details to be consulted).
[2] Relevant patent classifications, prior art references, and legal status reports from patent databases such as Espacenet and WIPO PATENTSCOPE.
[3] Market and patent landscape analyses derived from industry reports and patent analytics tools.
This analysis underscores the importance of detailed patent claim examination and landscape analysis in strategic decision-making within the pharmaceutical industry.
